Rhumbline Advisers Cytek Biosciences, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q4 2024

A detailed history of Rhumbline Advisers transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 294,539 shares of CTKB stock, worth $1.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

294,539

Previous 294,525 -0.0%

Holding current value

$1.68 Million

Previous $1.63 Million 17.17%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$4.7 - $7.4 $65 - $103	14 Added 0.0%	294,539 $1.91 Million
Q3 2024 Nov 12, 2024	SELL	$4.73 - $6.73 $288,109 - $409,931	-60,911 Reduced 17.14%	294,525 $1.63 Million
Q2 2024 Aug 01, 2024	BUY	$5.3 - $6.91 $96,057 - $125,236	18,124 Added 5.37%	355,436 $1.98 Million
Q1 2024 May 09, 2024	BUY	$6.29 - $9.15 $60,899 - $88,590	9,682 Added 2.96%	337,312 $2.26 Million
Q4 2023 Feb 08, 2024	BUY	$4.1 - $9.51 $23,115 - $53,617	5,638 Added 1.75%	327,630 $2.99 Million
Q3 2023 Nov 09, 2023	BUY	$5.52 - $9.5 $174,266 - $299,915	31,570 Added 10.87%	321,992 $1.78 Million
Q2 2023 Aug 08, 2023	BUY	$6.69 - $11.99 $943,657 - $1.69 Million	141,055 Added 94.44%	290,422 $2.48 Million
Q1 2023 May 11, 2023	BUY	$8.44 - $13.47 $57,425 - $91,649	6,804 Added 4.77%	149,367 $1.37 Million
Q4 2022 Feb 14, 2023	BUY	$9.71 - $15.86 $17,914 - $29,261	1,845 Added 1.31%	142,563 $1.46 Million
Q3 2022 Nov 10, 2022	BUY	$10.96 - $15.45 $128,790 - $181,552	11,751 Added 9.11%	140,718 $2.07 Million
Q2 2022 Aug 11, 2022	BUY	$7.41 - $11.56 $242,225 - $377,884	32,689 Added 33.95%	128,967 $1.38 Million
Q1 2022 May 12, 2022	BUY	$9.89 - $17.25 $805,589 - $1.41 Million	81,455 Added 549.52%	96,278 $1.04 Million
Q4 2021 Feb 10, 2022	BUY	$16.14 - $25.04 $49,420 - $76,672	3,062 Added 26.04%	14,823 $242,000
Q3 2021 Nov 12, 2021	BUY	$17.52 - $27.93 $206,052 - $328,484	11,761 New	11,761 $252,000

Others Institutions Holding CTKB

# of Institutions

134

Shares Held

71.7M

Call Options Held

400

Put Options Held

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $766M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Cytek Biosciences, Inc. Transaction History